In particular, established diabetic nephropathy treatments, including angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, insulin therapy, and metabolic disorder medications, have been investigated for their potential roles in modulating ferroptotic processes. This evidence concerns the gene INS and Other metabolic disease.